...
首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Advances in asthma, asthma-COPD overlap, and related biologics in 2018
【24h】

Advances in asthma, asthma-COPD overlap, and related biologics in 2018

机译:2018年哮喘,哮喘 - COPD重叠和相关生物制剂的进展

获取原文
获取原文并翻译 | 示例
           

摘要

Over the past year, numerous important advances in our understanding of multiple aspects of asthma, ranging from disease pathogenesis to epidemiology to therapeutics, have been reported. This review is a compilation of highlights from articles published largely in the Journal of Allergy and Clinical Immunology and supplemented by articles published elsewhere that have substantially advanced the fields of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap and biologic therapies for these disorders. The intention of this article is not to provide a comprehensive review but rather to focus on several areas that have developed quickly and/or received extensive attention from our readers.
机译:据报道,在过去的一年中,已经报道了我们对哮喘多个方面的许多重要进展,从疾病发病机病到治疗剂的流行病学。 该审查是从主要在过敏和临床免疫学杂志发表的文章中汇编的汇编,并通过在别处发表的文章,这些文章在其他地方发表的文章,这些文章大大提升了哮喘,慢性阻塞性肺病(COPD)和哮喘 - COPD重叠和生物疗法 对于这些疾病。 本文的目的不是提供全面的审查,而是专注于几个领域,这些领域已经快速和/或受到读者广泛关注的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号